Am. J. Respir. Crit. Care Med., Volume 162, Number 1, July 2000, 21-26

Selective NOS Inhibition Restores Myocardial Contractility in Endotoxemic Rats; However, Myocardial NO Content Does Not Correlate with Myocardial Dysfunction

IFEDIORA F. AFULUKWE, RUBIN I. COHEN, GUILLERMO A. ZEBALLOS, MOBEEN IQBAL, and STEVEN M. SCHARF

Division of Pulmonary/Critical Care Medicine, Long Island Jewish Medical Center, Albert Einstein College of Medicine, New Hyde Park, New York

The role of nitric oxide (NO) in lipopolysaccharide (LPS)-induced myocardial dysfunction remains controversial as some investigators concluded that inhibition of NO synthesis improves left ventricular (LV) contractility, whereas others did not. We investigated the relationship between LPS-induced LV dysfunction and LV NO production. We postulated that high myocardial NO concentrations would correspond to decreased contractility and low NO concentrations would correspond to recovery. In a rat model of endotoxemia, we used the isolated papillary preparation to assess inotropic dysfunction. We measured LV NO content and hemodynamics at baseline, 4, 16, and 48 h after LPS administration. LPS caused a decrease in LV contractility at 16 h with recovery at 48 h. Myocardial NO levels were elevated at all time periods. However, at 48 h in spite of normalization of LV contractility, myocardial NO content remained elevated. Pretreatment of LPS animals with the nonselective nitric oxide synthase (NOS) inhibitor N ^G-nitro-L-arginine methyl ester (L-NAME) worsened LV contractility, decreased LV NO content, and increased mortality. However, pretreatment with the relatively selective inducible NOS (iNOS) inhibitor S-methylisothiourea sulfate (SMT) restored LV contractility. Myocardial NO content in the SMT was lower than that of the LPS only group, but higher than the L-NAME group. We conclude that SMT is beneficial to myocardial contractility in this model of endotoxemia, whereas pretreatment with L-NAME is associated with further deterioration of contractility and increased mortality. Moreover, our data indicate that high myocardial NO concentrations do not necessarily correlate with decreased contractility.

This article has been cited by other articles:

				M. Fornai, C. Blandizzi, L. Antonioli, R. Colucci, N. Bernardini, C. Segnani, F. De Ponti, and M. Del Tacca Differential Role of Cyclooxygenase 1 and 2 Isoforms in the Modulation of Colonic Neuromuscular Function in Experimental Inflammation J. Pharmacol. Exp. Ther., June 1, 2006; 317(3): 938 - 945. [Abstract] [Full Text] [PDF]

				S. Natori, N. Hasebe, Y.-T. Jin, T. Matsusaka, A. Ido, H. Matsuhashi, T. Ihara, and K. Kikuchi Inhaled Nitric Oxide Modifies Left Ventricular Diastolic Stress in the Presence of Vasoactive Agents in Heart Failure Am. J. Respir. Crit. Care Med., March 15, 2003; 167(6): 895 - 901. [Abstract] [Full Text] [PDF]

				H. Sugita, M. Kaneki, E. Tokunaga, M. Sugita, C. Koike, S. Yasuhara, R. G. Tompkins, and J. A. J. Martyn Inducible nitric oxide synthase plays a role in LPS-induced hyperglycemia and insulin resistance Am J Physiol Endocrinol Metab, February 1, 2002; 282(2): E386 - E394. [Abstract] [Full Text] [PDF]

				R. I. COHEN, A.-M. HASSELL, K. MARZOUK, C. MARINI, S. F. LIU, and S. M. SCHARF Renal Effects of Nitric Oxide in Endotoxemia Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): 1890 - 1895. [Abstract] [Full Text] [PDF]

				M. J. TOBIN Critical Care Medicine in AJRCCM 2000 Am. J. Respir. Crit. Care Med., October 15, 2001; 164(8): 1347 - 1361. [Full Text] [PDF]